dr.suganthis

Dr. Suganthi. S
Department: 
Pharmacology
Designation: 
Associate Professor
OT: 
Academic Qualifications: 

MBBS, MD, DM (Clinical Pharmacology)

Special Area of Interest: 
Oncopharmacology, Clinical Pharmacology and Toxicology, Regulatory Pharmacology
Publication: 
  1. Muiwo P, Pandey P, Ahmad HM, Ramachandran SS, Bhattacharya A. IsomiR processing during differentiation of myelogenous leukemic cell line K562 by phorbol ester PMA. Gene. 2018 Jan 30;641:172-179.
  2. Ramachandran SS, Muiwo P, Ahmad HM, Pandey RM, Singh S, Bakhshi S, Kumar L, Bhattacharya A, Gupta YK. miR-505-5p and miR-193b-3p: potential biomarkers of imatinib response in patients with chronic myeloid leukemia. Leuk Lymphoma. 2017 Aug;58(8):1981-1984.
  3. Gupta YK, Ramachandran SS. Fixed dose drug combinations: Issues and challenges in India. Indian J Pharmacology 2016; 48:347-9.
  4. Ahmad HM, Muiwo P, Ramachandran SS, Pandey P, Gupta YK, Kumar L, Kulshreshtha R, Bhattacharya A. miR-22 regulates expression of oncogenic neuro-epithelial transforming gene 1, NET1. FEBS J. 2014 Sep; 281(17): 3904-19.
  5. Gupta YK, Ramachandran SS. Pharmacology of Aging, Textbook of Geriatric Medicine; 1st edition (2014), Paras Publishers, ISBN-10: 818191418X. (Book Chapter)
Positions Held: 
Address: 
Country: 
India